People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Pharmaceuticals, Other Health Care, Other
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| D&D Pharmatech Inc. | — | Pharmaceuticals | Series A | $10.8M | $36.0M | 2025 |
| Neuraly, Inc. | — | Other Health Care | Series A | $10.5M | $210.8M | 2016 |
| Theraly Fibrosis, Inc. | — | Pharmaceuticals | Series A | $5.6M | $153.0M | 2018 |
| Valted Seq, Inc. | — | Other | Seed | $2.5M | $37.7M | 2021 |
Seulki Lee at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Seulki Lee on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Viktor Roschke | 2 | 2 |
| Michael Kim | 1 | 14 |
| Young Hoon Kim | 1 | 2 |
| Seol-Heui Han | 1 | 1 |
| Seungwon Lim | 1 | 1 |
| Sunghoon Hong | 1 | 1 |
| Daehyun Shin | 1 | 1 |
| Sheri Si-Yu Fan | 1 | 1 |
| Ted Dawson | 1 | 1 |
| Valina Dawson | 1 | 1 |
| Sungmook Lim | 1 | 1 |
| Keele Park | 1 | 1 |
| Junghee Lim | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.